Market forecast analyses for West Nile virus (WNV) vaccine and anti-WNV monoclonal antibody for prophylaxis

The CDC’s Office of Acquisition Services awarded a contract to Precision Delivery Federal LLC to conduct market forecast analyses for a West Nile virus vaccine and an anti‑WNV monoclonal antibody intended for prophylaxis. The work will involve estimating market size, adoption rates, pricing dynamics, and potential revenue under various scenarios to support government decision‑making on vaccine and therapeutic development. The award amount is $296,250 and the contract is structured as a Time‑and‑Materials (T&M) agreement under NAICS 541715. • Scope: Market forecasting for WNV vaccine and monoclonal antibody prophylaxis. • Budget: $296,250 (award amount). • Agency: Centers for Disease Control and Prevention (CDC). • Vendor: Precision Delivery Federal LLC, based in Ames, Iowa.